PortugalPortugal

Portugal planted 60% more GMOs in 2011

07.10.2011

Lisbon – In the southwest of Europe, GMOs are gaining ground. According to the European Association for BioIndustries EuropaBio, Portuguese farmers have grown nearly 60% more genetically modified (GM) maize this year compared to last year, an increase of almost 3,000 ha to a total of 7,843 ha. Spanish figures have also increased this year, reaching nearly 100,000 hectares of GM maize. Currently, there are two GM crops approved for cultivation in the EU, the insect-resistant MON810 maize that helps to decrease European corn borer damage, as well as the Amflora potato for industrial uses.
“EU farmers are missing out on €440-930 million each year, simply because they do not have access to the GM crops that could be grown here", said Carel du Marchie Sarvaas, EuropaBio’s Director for Green Biotechnology Europe, on a recent study tour to Portugal. Sarvaas was referring to a 2008 study by the Joint Research Centre, that estimated that MON810 increased farm income by up to EUR122 per hectare, led to higher average yields of 11.8% in an area of heavy insect pressure, and resulted in a reduction in insecticide costs by as much as EUR20.04 per hectare. "Productivity needs to be increased", added Pedro Fevereiro, President of Centre for Biotechnology Information (CiB Portugal). "This technology is already proven to enable cultivars to attain their maximum potential, protecting the plants and the environment against pests, diseases and weeds, while creating products that are safe and healthy. These benefits have been experienced and accumulated all over the world for more than fifteen years. It is time for the European farmers to profit from this technology.”
In September 2005, the Portuguese government established a decree law (No. 160/2005) on the co-existence between genetically modified organisms (GMO), conventional and organic crops. In brief, it recommends a minimum distance of 200 meters between biotech and conventional crops, or a 300-meter distance between bio­tech and organic corn plots, and establishes a framework for GMO-free regions

PortugalPortugal

19.08.2008

Lisbon – The international contract research organisation Chiltern sees potential for growth in Portugal. In May, it opened a new office in Lisbon that will be managed by Ricardo Diaz. Over the last two years, numbers of clinical...

PortugalPortugal

19.03.2008

Porto – 164 farmers planted a total of 4,199 hectares of genetically modified maize in Portugal in 2007, according to a report issued by the Portuguese Ministry of Agriculture. That represents a 330% increase compared to 2006,...

PortugalPortugal

22.11.2007

Cantanhede – Biogen Idec (Cambridge, US) and the Portuguese biopark Biocant in the Coimbra region have signed a socalled ‘Sponsored Research Agreement’ worth an undisclosed amount. Under the terms of the agreement, researchers...

Portugal, SpainPortugal

11.07.2007

Oeiras/Navarra – Portuguese antibody and genomics specialist Biotecnol SA and the Spanish university spin-off Digna Biotech will develop a process for manufacturing cardiotrophin-1 (CT-1) for the treatment of ischemic-reperfusion...

PortugalPortugal

11.07.2007

Porto – In September 2005, the Portuguese government established a decree law (No. 160/2005) on the co-existence between genetically modified organisms (GMO), conventional and organic crops. In short, it recommends a minimum...

PortugalPortugal

11.07.2007

Almada – transADVANcis Lda, a consultancy firm for nanotechnology and life sciences executives, has launched a website called www.nanogolive.com. With the new portal, on which anyone from the nanotechnology and life science...

PortugalPortugal

16.05.2007

Porto – Two Portuguese biotech companies have won the national idea contest for bio-entrepreneurs (Concurso de Ideias Bioempreendedor 2006), organized every year by the Portuguese Association of Bioindustries (APBio) and the...

PortugalPortugal

16.03.2007

Port Salvo – Biotrend S.A., developers of high-value compounds based in Lisbon, has closed a second investment round with the public venture capital outfit PME Investimientos, ending with a total investment exceeding 1 million...

PortugalPortugal

16.03.2007

Porto Salvo – Alfama, developers of small molecule drugs, has opened a laboratory in Boston, Massachusetts, in order to achieve US presence. The company will carry out research on the effects of self-developed molecules on...

Italy, PortugalPortugal

16.09.2006

Milan/Sintra – The Italian pharmaceutical company Recordati S.p.A agreed in July to acquire Jaba Farmacêutica (Sintra, Portugal) and all other pharmaceutical businesses belonging to the Grupo Jaba in Portugal. The purchase price...

Displaying results 11 to 20 out of 37

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-portugal/browse/1/article/portugal-planted-60-more-gmos-in-2011.html

Events

All Events

Stock list

All quotes

TOP

  • MOLOGEN7.85 EUR5.65%
  • CYTOS0.26 CHF4.00%
  • PAION2.48 EUR2.06%

FLOP

  • 4SC1.25 EUR-2.34%
  • FORMYCON6.75 EUR-1.75%
  • VITA 343.75 EUR-1.57%

TOP

  • SANTHERA83.50 CHF21.8%
  • MAGFORCE6.90 EUR10.8%
  • BB BIOTECH140.45 EUR5.1%

FLOP

  • WILEX2.36 EUR-25.1%
  • MOLOGEN7.85 EUR-19.5%
  • VITA 343.75 EUR-17.6%

TOP

  • SANTHERA83.50 CHF3695.5%
  • CO.DON2.61 EUR226.2%
  • PAION2.48 EUR188.4%

FLOP

  • CYTOS0.26 CHF-93.5%
  • MEDIGENE4.48 EUR-68.1%
  • MERCK KGAA66.20 EUR-43.4%

No liability assumed, Date: 26.08.2014


Current issue

All issues

Product of the week

Products